|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/36 | (2006.01) |
| A61K 38/4846 | (2013.01) | ||
| A61K 38/48 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/31 | (2013.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61K 38/4833 | (2013.01) | ||
| C07K 16/36 | (2013.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Patento numeris | 3283099 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16718244.3 |
| Europos patento paraiškos padavimo data | 2016-04-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-03-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/057662 |
| Data | 2016-04-07 |
| (87) | Numeris | WO 2016/166014 |
| Data | 2016-10-20 |
| (30) | Numeris | Data | Šalis |
| 15164045 | 2015-04-17 | EP |
| (72) |
CALATZIS, Andreas , DE
LECHNER, Katharina , DE
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY WITH COAGULATION FACTORS AND MULTISPECIFIC ANTIBODIES |
| COMBINATION THERAPY WITH COAGULATION FACTORS AND MULTISPECIFIC ANTIBODIES |